Back to top

stock-price-change: Archive

Zacks Equity Research

Recent Price Trend in Climb Global (CLMB) is Your Friend, Here's Why

If you are looking for stocks that are well positioned to maintain their recent uptrend, Climb Global (CLMB) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.

CLMBNegative Net Change

Shreya Majumder

Can CRWV Turn Its $132.5B Backlog Into Durable, Profitable AI Growth?

CoreWeave's $132.5B backlog signals massive AI demand, but rising interest costs and infrastructure execution challenges could delay its profitability payoff.

CRWVNegative Net Change MSFTNegative Net Change NVDANegative Net Change

Zacks Equity Research

Kuehne & Nagel International (KHNGY) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?

Kuehne & Nagel International (KHNGY) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.

KHNGYNegative Net Change

Zacks Equity Research

Rithm (RITM) Could Find a Support Soon, Here's Why You Should Buy the Stock Now

After losing some value lately, a hammer chart pattern has been formed for Rithm (RITM), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.

RITMNegative Net Change

Zacks Equity Research

Here's Why Rexel SA - Unsponsored ADR (RXEEY) Is a Great 'Buy the Bottom' Stock Now

Rexel SA - Unsponsored ADR (RXEEY) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.

RXEEYNegative Net Change

Zacks Equity Research

Galectin Therapeutics (GALT) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?

Galectin Therapeutics (GALT) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.

GALTNegative Net Change

Zacks Equity Research

Nephros (NEPH) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now

Nephros (NEPH) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.

NEPHNegative Net Change

Zacks Equity Research

KANZHUN LIMITED Sponsored ADR (BZ) Earnings Expected to Grow: Should You Buy?

Kanzhun (BZ) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

BZNegative Net Change VNETNegative Net Change

Zacks Equity Research

Deere (DE) Earnings Expected to Grow: Should You Buy?

Deere (DE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

DENegative Net Change

Zacks Equity Research

Texas Instruments (TXN) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now

Texas Instruments (TXN) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.

TXNNegative Net Change